Want to join the conversation?
$PRU 2Q15 Q&A: On a question asked by Bhullar of JPMorgan about DOL fiduciary standard approval impact, Steve said, PRU see it as a net negative on the marketplace that it serves; see the risk of individuals having restricted access to advise certain type of solution particularly around guaranteed retirement income solutions.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?